<DOC>
	<DOCNO>NCT02410083</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tolerability Clopirin clopidogrel aspirin Korean Patients post-percutaneous coronary artery intervention .</brief_summary>
	<brief_title>Trial Assess Efficacy Combination Formula Aspirin Plus Clopidogrel Patients With Coronary Stent</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Coronary Aneurysm</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Over 3 month , patient administration aspirin coadministration clopidogrelaspirin coronary artery patient treat Percutaneous Coronary Intervention ( PCI ) safety progress . Korean men woman age 20 85 Patients understand study requirement , willing comply study procedure provide write informed consent . Patients treat PCI intend treat PCI fail . Patients take take antiplatelet anticoagulant 2 week within prior 30 day . Patients history alcohol abuse intoxication . Patients hypersensitivity clopidogrel aspirin . Patients severe hepatic dysfunction aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 3 time upper normal reference value . Patients blood coagulation disorder , uncontrolled severe hypertension , active bleeding , history severe bleeding , intracranial hemorrhage ulcer bleed surgery within 48hr , platelet count 50,000/mm3 laboratory test . Patients pregnant , breastfeed . Patients use effective method contraception . ( proper contraception : hormonal contraception , condom , intrauterine device , spermicide ) Patients medically , psychologically investigational product administration 's prohibition . Patients participate clinical trial decide investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>